Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1996 1
1999 2
2000 4
2001 4
2002 3
2003 3
2004 4
2005 5
2006 6
2007 6
2008 3
2009 8
2010 4
2011 4
2012 6
2013 3
2014 5
2015 11
2016 12
2017 12
2018 16
2019 9
2020 11
2021 17
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

138 results
Results by year
Filters applied: . Clear all
Page 1
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA.
Le Gouill S, Ghesquières H, Oberic L, Morschhauser F, Tilly H, Ribrag V, Lamy T, Thieblemont C, Maisonneuve H, Gressin R, Bouhabdallah K, Haioun C, Damaj G, Fornecker L, Bouhabdallah R, Feugier P, Sibon D, Cartron G, Bonnet C, André M, Chartier L, Ruminy P, Kraeber-Bodéré F, Bodet-Milin C, Berriolo-Riedinger A, Brière J, Jais JP, Molina TJ, Itti E, Casasnovas RO. Le Gouill S, et al. Among authors: itti e. Blood. 2021 Apr 29;137(17):2307-2320. doi: 10.1182/blood.2020008750. Blood. 2021. PMID: 33211799 Free article.
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation.
Cazelles C, Belhadj K, Vellemans H, Camus V, Poullot E, Gaulard P, Veresezan L, Itti E, Becker S, Carvalho M, Dupuis J, Le Bras F, Lemonnier F, Roulin L, El Gnaoui T, Jardin F, Mounier N, Tilly H, Haioun C. Cazelles C, et al. Among authors: itti e. Leuk Lymphoma. 2021 Sep;62(9):2161-2168. doi: 10.1080/10428194.2021.1901090. Epub 2021 Mar 25. Leuk Lymphoma. 2021. PMID: 33764240
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Among authors: itti e. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Whole-Body Functional MRI and PET/MRI in Multiple Myeloma.
Mulé S, Reizine E, Blanc-Durand P, Baranes L, Zerbib P, Burns R, Nouri R, Itti E, Luciani A. Mulé S, et al. Among authors: itti e. Cancers (Basel). 2020 Oct 27;12(11):3155. doi: 10.3390/cancers12113155. Cancers (Basel). 2020. PMID: 33121132 Free PMC article. Review.
FDG PET/CT imaging as a biomarker in lymphoma.
Meignan M, Itti E, Gallamini A, Younes A. Meignan M, et al. Among authors: itti e. Eur J Nucl Med Mol Imaging. 2015 Apr;42(4):623-33. doi: 10.1007/s00259-014-2973-6. Epub 2015 Jan 9. Eur J Nucl Med Mol Imaging. 2015. PMID: 25573631 Review.
Whole-body diffusion-weighted imaging in lymphoma.
Lin C, Itti E, Luciani A, Haioun C, Meignan M, Rahmouni A. Lin C, et al. Among authors: itti e. Cancer Imaging. 2010 Oct 4;10 Spec no A(1A):S172-8. doi: 10.1102/1470-7330.2010.9029. Cancer Imaging. 2010. PMID: 20880782 Free PMC article. Review.
Lymph node imaging: basic principles.
Luciani A, Itti E, Rahmouni A, Meignan M, Clement O. Luciani A, et al. Among authors: itti e. Eur J Radiol. 2006 Jun;58(3):338-44. doi: 10.1016/j.ejrad.2005.12.038. Epub 2006 Feb 13. Eur J Radiol. 2006. PMID: 16473489 Review.
138 results